Bangkok--Oct 30--Pfizer Corporation
Pfizer Corporation has maintained its top position in the pharmaceuticals industry, according to the 1998 edition of Fortune magazine s “The World s Most Admired Companies”. The annual survey, a respected assessment of companies in 21 diverse industries ranging from aerospace to commercial banking to entertainment to telecommunications, is compiled by speaking to senior executives and outside directors in each of the industries, in addition to specialist financial analysts in the given field.
These industry insiders were asked to rate each company on eight criteria, comprising: overall management quality, products or service quality, innovativeness, value as a long-term investment, financial strength, responsibility to the community and environment, and wise use of corporate assets. To reflect the survey s international scope, a ninth category was added this year asking respondents to rate how effective each company is in doing business globally. A company s overall ranking is the average of the scores of all nine attributes.
Pfizer once again outpaced the competition in retaining the number one spot in the pharmaceuticals sector, achieving an overall score in the Fortune survey of 8.58. Pfizer s consistent position at the head of the industry is a reflection of the firm s commitment to innovation through research and development (R&D). Pfizer has more than doubled R&D expenditures in the last 5 years and will invest in excess of US$2 billion in 1998.
In the past two years alone, Pfizer has participated in the development of new treatments for migraine, irritable bowel syndrome, male impotence, osteoarthritis, cardiac arrhythmias, schizophrenia, breast cancer and panic disorder, to name a few. More impressive still is Pfizer s showing in the all-star list, a category that Fortune has added to this year s survey. The all-star list was derived by asking respondents to select the five companies they most admire (from any industry), with the final list ranking the 25 companies that garnered the greatest number of individual votes. Pfizer placed eighth on this all-star list, behind other global powerhouses such as General Electric, Coca-Cola, Microsoft, Intel and Hewlett-Packard.
Commenting on the company s consistently strong showing in the annual Fortune survey, Ms. Beyhan D. Zaim, General Manager, Thailand/Myanmar, Pfizer Pharmaceuticals, noted that “it is extremely satisfying to know that independent professionals and industry analysts have once again selected Pfizer as the world s most admired pharmaceuticals company. The ranking is a positive reflection of our research-based approach, which has allowed us to launch a consistent stream of innovative new products, including ten new products in the last decade and two additional product launches in 1998.
“Pfizer s extensive research network spans the globe, and we are able to draw upon the expertise of individuals in each of our three state-of-the-art research facilities. In total, Pfizer employs over 4,700 dedicated research professionals around the world. Viagra, the breakthrough oral medication in the treatment of male erectile dysfunction, is a prime example of our industry leadership in that it is a culmination of almost 15 years of Pfizer R&D efforts, highlighting this research focus,” Ms. Zaim concluded.
For further information, please contact: Tel: 273 8800 Fax: 273 8880. End.